|
Press Releases |
|
|
|
Tuesday, October 24, 2017 |
|
Singapore eDevelopment's Global BioLife develops Low-GI Modified Sugar |
SGX-listed Singapore eDevelopment Ltd ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has developed a breakthrough low-calorie, low glycemic index, natural, modified sugar Laetose -- which has the potential to affect the world's sugar market. more info >> |
|
Thursday, October 19, 2017 |
|
ASX-Listed Holista and Holista Foods Inc. (USA) Develop Breakthrough Noodle Formula with Low-Glycemic Score of 38 |
Australian Securities Exchange-listed food ingredient specialist Holista CollTech Ltd (ASX: HCT, "Holista") announced today that it has developed a breakthrough noodle formula certified to have a low Glycemic Index ("GI") - opening a major market for a healthier version of the staple which is vital in the global fight against diabetes and obesity. more info >> |
|
Tuesday, August 15, 2017 |
|
Singapore eDevelopment's Global BioLife and Chemia Corp. to develop 3F suite of Functional Fragrances |
Singapore eDevelopment Ltd (SeD; SGX:SGE) has announced that its indirect subsidiary, Global BioLife Inc., is collaborating with U.S.-based Chemia Corporation to develop specialised fragrances which can counter mosquito-borne diseases, diminish stress and anxiety, and act in anti-viral medical applications. more info >> |
|
Monday, May 22, 2017 |
|
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform |
Singapore eDevelopment Limited ("SeD") subsidiary Global BioLife Inc. has initiated advanced research of a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
云想科技2023年总账单再创新高 达人民币81.37亿元
Mar 29, 2024 12:55 HKT/SGT
|
|
|
云想科技2023年總賬單再創新高 達人民幣81.37億元
Mar 29, 2024 12:49 HKT/SGT
|
|
|
Netjoy records new high gross billing hitting RMB8.137 billion in 2023
Mar 29, 2024 12:27 HKT/SGT
|
|
|
中国生物制药(1177.HK)公布2023全年业绩
Mar 29, 2024 12:15 HKT/SGT
|
|
|
中國生物製藥(1177.HK)公布2023全年業績
Mar 29, 2024 12:09 HKT/SGT
|
|
|
Sino Biopharm (1177.HK) Announces 2023 Annual Results
Mar 29, 2024 11:45 HKT/SGT
|
|
|
Wintermar Offshore (WINS:JK) Reports FY2023 Results
Mar 29, 2024 10:15 HKT/SGT
|
|
|
TANAKA Memorial Foundation Announces Recipients of Precious Metals Research Grants
Mar 29, 2024 11:00 JST
|
|
|
Fujitsu Selected as CDP Supplier Engagement Leader
Mar 29, 2024 10:28 JST
|
|
|
Mazda Production and Sales Results for February 2024
Mar 29, 2024 10:00 JST
|
|
|
Finerca Celebrates Milestone of 10,000 Clients with Launch of Exclusive Master Course in CFD Trading
Mar 29, 2024 06:48: JST
|
|
|
Avance Clinical은 세계 백신 대회에서 최신 백신 임상시험 뉴스를 공유합니다. 이 중에는 HIV-1 연구도 포함됩니다
Mar 29, 2024 06:42 HKT/SGT
|
|
|
Avance Clinical將在世界疫苗大會上分享最新的疫苗臨床試驗新聞,包括HIV-1研究
Mar 29, 2024 06:33 HKT/SGT
|
|
|
Avance Clinical将在世界疫苗大会上分享最新的疫苗临床试验新闻,包括HIV-1研究
Mar 29, 2024 06:22 HKT/SGT
|
|
|
703-Carat L'Heure Bleu Tanzanite Carving Sets New GUINNESS WORLD RECORDS(TM) Title as World's Largest Cut Tanzanite
Mar 29, 2024 06:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|